Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Groundbreaking Hydrogel Implant to Help Prevent Endometriosis

By HospiMedica International staff writers
Posted on 18 Jul 2024

Approximately 10% of women are affected by endometriosis, a condition whose origins remain largely unknown. More...

One prevailing theory suggests that endometriosis develops when menstrual blood, carrying cells from the uterine lining, flows backward through the fallopian tubes into the abdominal cavity, where it may cause inflammation, pain, and scar tissue. To address this, researchers have developed a hydrogel implant that effectively blocks the fallopian tubes to stop the backflow of menstrual blood, potentially reducing the risk of developing endometriosis. This implant is designed to be biocompatible, easy to apply, and removable either through exposure to UV light or a special solution, based on tests indicating it does not provoke a foreign body response.

Hydrogels, which are versatile polymers capable of retaining water, have applications ranging from contact lenses to soil hydration. A collaborative effort by teams from ETH Zurich (Zurich, Switzerland) and Empa (Zurich, Switzerland) has led to the creation of this novel hydrogel implant, as reported in a recent publication in the journal Advanced Materials. This dual-purpose implant serves as both a contraceptive and a preventative measure against endometriosis. Introduced non-surgically via a hysteroscope, the hydrogel swells upon contact with bodily fluids, effectively blocking both sperm and menstrual blood from passing through the fallopian tubes.

The researchers meticulously tested the implant's stability and degradability, striving to strike a balance that ensures long-term compatibility and effectiveness. Initial testing was performed ex-vivo on human and animal fallopian tubes removed during medical procedures like ovarian cancer surgery, followed by in-vivo testing in a live pig where the implant remained stable and non-reactive after three weeks. While a patent has been filed for this technology, further development and testing are necessary to prepare it for commercial use. The researchers are actively seeking partnerships within industry and academia to advance this innovation, particularly considering the unique challenges posed by human application and activities such as sports. Additionally, it remains to be seen if blocking the fallopian tubes alone will be enough to fully prevent endometriosis.

“So far, very little research has been done at the point where materials science, process engineering and gynecology meet. But this is a vitally important area of research. We hope that our work will count as a meaningful step in the right direction,” said Inge Herrmann , a member of the research group at the Department of Mechanical and Process Engineering at ETH and Empa.

Related Links:
ETH Zurich
Empa


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Rapid Sepsis Test
SeptiCyte RAPID
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.